Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Cardiovascular Disease
Interventions
DRUG

Fenofibrate (Tricor) tablets

One 145 mg tablet taken once daily, in the evening, with food, for 6 to 8 weeks

DRUG

Placebo

Two placebo capsules taken twice daily, morning and evening, with food and one placebo gel capsule taken once daily, in the evening, with food, for 6 to 8 weeks

DRUG

Lovaza

900 mg/day: One 900 mg capsule taken once daily, morning or evening; or 3,600 mg/day: Two 900 mg capsules taken twice daily, morning and evening; All capsules to be taken with food, for 6 to 8 weeks.

Trial Locations (1)

19104

Clinical and Translational Research Center (CTRC); Hospital of the University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT01048502 - Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia | Biotech Hunter | Biotech Hunter